Kinnate Biopharma Inc (KNTE)

NASDAQ
23.11
-0.07(-0.30%)
  • Volume:
    77,807
  • Bid/Ask:
    22.00/31.40
  • Day's Range:
    22.27 - 23.56

KNTE Overview

Prev. Close
23.11
Day's Range
22.27-23.56
Revenue
-
Open
22.76
52 wk Range
21.27-48.59
EPS
-
Volume
77,807
Market Cap
1.01B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
135,040
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
43,504,484
Next Earnings Date
Sep 01, 2021
What is your sentiment on Kinnate Biopharma Inc?
or
Market is currently closed. Voting is open during market hours.

Kinnate Biopharma Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellSell
Technical IndicatorsBuyBuyStrong SellStrong SellBuy
SummaryNeutralNeutralStrong SellStrong SellNeutral

Kinnate Biopharma Inc Company Profile

Kinnate Biopharma Inc Company Profile

Sector
Services
Employees
31

Kinnate Biopharma Inc. is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The Company utilizes its deep specialization in structure-based drug discovery, translational research and patient-driven precision medicine, which is collectively referred as Kinnate Discovery Engine, to develop its targeted therapies. The Company’s advanced product candidate is KIN002787, which is a rapidly accelerated fibrosarcoma (RAF) inhibitor, which is being developed for the treatment of patients with lung cancer, melanoma and other solid tumors. The Company’s other product candidate include KIN003 and KIN004.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.